\label{fig:2} 
\textbf{GFP::DmCa\textsubscript{v}3 expression in the adult brain} 
\\ 
\textbf{(a)} Gene targeting and \emph{GFP::DmCa\textsubscript{v}3} generation strategy. 
DmCa\textsubscript{v}3 coding exons are red.
\textbf{(b)} Adult brain expression of \emph{GFP::DmCa\textsubscript{v}3} (green) divided into maximal intensity projections of confocal stacks from the anterior \textbf{(b1)}, middle \textbf{(b2)}, and posterior \textbf{(b3)} brain.
\textbf{(c-h)} GFP::DmCa\textsubscript{v}3 expression in specific neuropils whose location corresponds to the boxed areas in (b).
\textbf{(c)} Expression in the antennal lobes (AL) and subesophageal ganglia (SOG).
\textbf{(d)} Expression in the mushroom body (MB) lobes ($\alpha$, $\beta$, and $\alpha$'). 
\textbf{(e)} Expression in fan-shaped body (FB), ellipsoid body (EB), and noduli (NO) of the central complex.
\textbf{(f)} Expression in the anterior \textbf{(f1)} and posterior \textbf{(f2)} mushroom body (MB) peduncles.
\textbf{(g)} Expression in the protocerebral bridge (PB) of the central complex. 
\textbf{(h)} Expression in the mushroom body (MB) calyx. 
Neuropils are counter-stained with the nc82 antibody ($\alpha$-Bruchpilot, magenta).
